본문 바로가기
HOME> 논문 > 논문 검색상세

논문 상세정보

Archives of pharmacal research : a publication of the Pharmaceutical Society of Korea v.33 no.6, 2010년, pp.821 - 830   SCIE 피인용횟수: 1
본 등재정보는 저널의 등재정보를 참고하여 보여주는 베타서비스로 정확한 논문의 등재여부는 등재기관에 확인하시기 바랍니다.

Synthesis and Antimicrobial and Nitric Oxide Synthase Inhibitory Activities of Novel Isothiourea Derivatives

Kazimierczuk, Zygmunt    (Department of Experimental Pharmacology, Polish Academy of Sciences   ); Chalimoniuk, Malgorzata    (Department of Cellular Signaling, Mossakowski Medical Research Center, Polish Academy of Sciences   ); Laudy, Agnieszka Ewa    (Department of Pharmaceutical Microbiology, Medical University of Warsaw   ); Moo-Puc, Rosa    (Unidad Interinstitucional de Investigacion Clinica y Epidemiologica, Facultad de Medicina, UADY/Instituto Mexicano del Seguro Social   ); Cedillo-Rivera, Roberto    (Unidad Interinstitucional de Investigacion Clinica y Epidemiologica, Facultad de Medicina, UADY/Instituto Mexicano del Seguro Social   ); Starosciak, Bohdan Jerzy    (Department of Pharmaceutical Microbiology, Medical University of Warsaw   ); Chrapusta, Stanislaw J.    (Department of Experimental Pharmacology, Polish Academy of Sciences  );
  • 초록

    The reaction of substituted benzylhalides, or of halomethyl derivatives of thiophene or furane, with thiourea or its derivatives yielded the respective isothioureas as hydrohalide salts. The products (a total of 17, including 16 novel compounds) were tested for activity against five Gram-positive and nine Gram-negative bacterial strains, six yeast species and two protozoan species. The most active against Gram-positive bacteria were S-(2,4-dinitrobenzyl)isothiourea hydrochloride (MIC range for four out of five strains tested: $12.5-25\;{\mu}g$ /mL) and S-(2,3,4,5,6-pentabromobenzyl)isothiourea hydrobromide (MIC range: $12.5-50\;{\mu}g$ /mL). The lowest MICs of novel isothioureas for yeast and Gram-negative bacteria ranged between 50 and $100\;{\mu}g$ /mL. Nine novel isothioureas showed appreciable genotoxicity in the Bacillus subtilis 'rec-assay' test, the most potent being S-2-(5-nitrofuran-2-ylmethyl)isothiourea and S-(2-nitrobenzyl) isothiourea. At $10\;{\mu}M$ concentration, S-(3,4-dichlorobenzyl)isothiourea hydrochloride and S-(2,3,4,5,6-pentabromobenzyl)isothiourea hydrobromide inhibited $Ca^{2+}$ /calmodulin-dependent (non-inducible) nitric oxide synthase activity in normal rat brain homogenates stronger (p

  • 주제어

    Isothiourea derivative .   Synthesis .   Antibacterial activity .   Antifungal activity .   Anti-protozoal activity .   Nitric oxide synthase.  

  • 참고문헌 (41)

    1. Babu, B. R. and Griffith, O. W., Design of isoform-selective inhibitors of nitric oxide synthase. Curr. Opin. Chem. Biol., 2, 491-500 (1998). 
    2. Barocelli, E., Ballabeni, V., Ghizzardi, P., Cattanuzza, F., Bertoni, S., Lagrasta, C. A. M., and Impiccatore, M., The selective inhibition of inducible nitric oxide synthase prevents instestinal ischemia-reperfusion injury in mice. Nitric Oxide, 14, 212-218 (2006). 
    3. Blattner, F. R., Plunkett, G. 3rd, Bloch, C. A., Perna, N. T., Burland, V., Riley, M., Collado-Vides, J., Glasner, J. D., Rode, C. K., Mayhew, G. F., Gregor, J., Davis, N. W., Kirkpatrick, H. A., Goeden, M. A., Rose, D. J., Mau, B., and Shao, Y., The complete genome sequence of Escherichia coli K-12. Science, 277, 1453-1462 (1997). 
    4. Castano, T., Encinas, A., Perez, C., Castro, A., Campilo, N. E., and Gil, C., Design, synthesis, and evaluation of potential inhibitors of nitric oxide synthase. Bioorg. Med. Chem., 16, 6193-6206 (2008). 
    5. Cedillo-Rivera, R. and Munoz, O., In vitro susceptibility of Giardia lamblia to albendazole, mebendazole and other chemotherapeutic agents. J. Med. Microbiol., 37, 221-224 (1992). 
    6. Cedillo-Rivera, R., Tapia-Contreras, A., Torres, J., and Munoz, O., In vitro susceptibility of Entamoeba histolytica to fluoroquinolones, nitrofurans and other antiamebic agents. Arch. Med. Res., 28 (Spec. iss.), 295-297 (1997). 
    7. Clinical and Laboratory Standards Institute, Performance standards for antimicrobial disk susceptibility tests. Approved standard - ninth edition. CLSI document M2-A9, Wayne, PA, USA (2006a). 
    8. Clinical and Laboratory Standards Institute, Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard - seventh edition. CLSI document M7-A7, Wayne, PA, USA (2006b). 
    9. del Campo, R., Criado, J. J., Gheorghe, R., Gonzalez, F. J., Hermosa, M. R., Sanz, F., Mazano, J. L., Monte, E., and Rodriguez-Fernandez, E., N-benzoyl-N'-alkylthioureas and their complexes with Ni(II), Co(III) and Pt(II) - crystal structure of 3-benzoyl-1-butyl-1-methyl-thiourea: activity against fungi and yeast. J. Inorg. Biochem., 98, 1307-1314 (2004). 
    10. Eissa, A. A. and Moneer, A. A., Synthesis and antimicrobial activity of novel tetrahydrobenzothienopyrimidines. Arch. Pharm. Res., 27, 885-892 (2004). 
    11. Garvey, E. P., Oplinger, J. A., Tanoury, G. J., Sherman, P. A., Fowler, M., Marshall, S., Harmon, M. F., Paith, J. E., and Furfine, E. S., Potent and selective inhibition of human nitric oxide synthases. Inhibition by non-amino acid isothioureas. J. Biol. Chem., 269, 26669-26676 (1994). 
    12. Handy, R. L., Wallace, P., and Moore, P. K., Inhibition of nitric oxide synthase by isothioureas: cardiovascular and antinociceptive effects. Pharmacol. Biochem. Behav., 55, 179-184 (1996). 
    13. Ijuin, R., Umezawa, N., Nagai, S., and Higuchi, T., Evaluation of 3-substituted arginine analogs as selective inhibitors of human nitric oxide synthase isozymes. Bioorg. Med. Chem. Lett., 15, 2881-2885 (2005). 
    14. Iwai, N., Nagai, K., and Wachi, M., Novel S-benzylisothiourea compound that induces spherical cells in Escherichia coli probably by acting on a rod-shape-determining protein(s) other than penicillin-binding protein 2. Biosci. Biotechnol. Biochem., 66, 2658-2662 (2002). 
    15. Jin, G. H., Lee, D. Y., Cheon, Y. J., Gim, H. J., Kim D. H., Kim, H. D., Ryu, J. H., and Jeon, R., Synthesis of phenylisothiourea derivatives as inhibitors of NO production in LPS activated macrophages. Bioorg. Med. Chem. Lett., 19, 3088-3092 (2009). 
    16. Kada, T., Hirano, K., and Shirasu, Y., Bacillus subtilis recassay test. In de Sevres, F. E. and Hollaender, A. (Eds.). Chemical Mutagens, vol. 6, Plenum Press, New York, pp. 149, (1980). 
    17. Kaminska, B., Ellert-Miklaszewska, A., Oberbek, A., Wisniewski, P., Kaza, B., Makowska, M., Bretner, M., and Kazimierczuk, Z., Efficacy and mechanism of anti-tumor action of new potential CK2 inhibitors toward glioblastoma cells. Int. J. Oncol., 35, 1091-1100 (2009). 
    18. Kang, I. J., Wang, L. W., Lee, C. C., Lee, Y. C., Chao, Y. S., Hsu, T. A., and Chern, J. H., Design, synthesis, and anti- HCV activity of thiourea compounds. Bioorg. Med. Chem. Lett., 19, 1950-1955 (2009). 
    19. Khan, S. A., Singh, N., and Saleem, K., Synthesis, characterization and in vitro antibacterial activity of thiourea and urea derivatives of steroids. Eur. J. Med. Chem., 43, 2272-2277 (2008). 
    20. Li, H. Q., Lv, P. C., Yan, T., and Zhu, H. L., Urea derivatives as anticancer agents. Anticancer Agents Med. Chem., 9, 471-480 (2009a). 
    21. Li, J., Tan, Z., Tang, S., Hewlett, I., Pang, R., He, M., He, S., Tian, B., Chen, K., and Yang, M., Discovery of dual inhibitors targeting both HIV-1 capsid and human cyclophilin A to inhibit the assembly and uncoating of the viral capsid. Bioorg. Med. Chem., 17, 3177-3188 (2009b). 
    22. Nicholson, A., Perry, J. D., James, A. L., Stanforth, S. P., De Soyza, A., and Gould, K., Antimicrobial activity of novel S- (benzyl) isothiourea derivatives against multiply resistant Pseudomonas aeruginosa and Burkholderia cepacia complex from patients with cystic fibrosis undergoing lung transplant assessment. J. Heart Lung Transplant., 28, S160 (2009). 
    23. Paesano, N., Marzocco, S., Vicidomini, C., Saturnino, C., Autore, G., De Martino, G., and Sbardella, G., Synthesis and biological evaluation of 3-benzyl-1-methyl- and 1- methyl-3-phenyl-isothioureas as potential inhibitors of iNOS. Bioorg. Med. Chem. Lett., 15, 539-543 (2005). 
    24. Paquay, J. B., Hoen, P. A., Voss, H. P., Bast, A., Timmerman, H., and Haenen, G. R., Nitric oxide synthase inhibition by dimaprit and dimaprit analogues. Br. J. Pharmacol., 127, 331-334 (1999). 
    25. Rodriguez-Fernandez, E., Mazano, J. L., Benito, J. J., Hermosa, M. R., Monte, E., and Criado, J. J., Thiourea, triazole and thiadiazine compounds and their metal complexes as antifungal agents. J. Inorg. Biochem., 99, 1558-1572 (2005). 
    26. Sadaie, Y. and Kada, T., Recombination-deficient mutants of Bacillus subtilis. J. Bacteriol., 125, 489-500 (1976). 
    27. Salerno, L., Sorrenti, V., Di Giacomo, C., Romeo, G., and Siracusa, M. A., Progress in the development of selective nitric oxide synthase (NOS) inhibitors. Curr. Pharm. Des., 8, 177-200 (2002). 
    28. Shearer, B. G., Lee, S., Oplinger, J. A., Frick, L. W., Garvey, E. P., and Furfine, E. S., Substituted N-phenylisothioureas: potent inhibitors of human nitric oxide synthase with neuronal isoform selectivity. J. Med. Chem., 40, 1901-1905 (1997). 
    29. Shirota, F. N., Stevens-Johnk, J. M., DeMaster, E. G., and Nagasawa H. T., Novel prodrugs of cyanamide that inhibit aldehyde dehydrogenase in vivo. J. Med. Chem., 40, 1870-1875 (1997). 
    30. Southan, G. J., Szabo, C., and Thiemermann, C., Isothioureas: potent inhibitors of nitric oxide synthases with variable isoform selectivity. Br. J. Pharmacol., 114, 510-516 (1995). 
    31. Tait, A., Di Bella, M., Bondi, M., Quaglio, G., and Fabio, U., Carbamimidothioic acid phenylmethyl ester salts and their N,N'-tetramethyl derivatives as possible antimicrobial agents. Farmaco, 45, 617-630 (1990). 
    32. Tait, A., Giovannini, M. G., Di Bella, M., Bondi, M., and Quaglio, G.P., S-Aryl(tetramethyl)isothiouronium salts as possible antimicrobial agents, IV. Farmaco, 44, 1129-1140 (1989). 
    33. Thoma, G., Streiff, M. B., Kovarik, J., Glickman, F., Wagner, T., Beerli, C., and Zerwes, H. G., Orally bioavailable isothioureas block function of the chemokine receptor CXCR4 in vitro and in vivo. J. Med. Chem., 51, 7915-7920 (2008). 
    34. Wang, Y., Lawson, J. A., and Jaeschke, H., Differential effect of 2-aminoethyl-isothiourea, an inhibitor of the inducible nitric oxide synthase, on microvascular blood flow and organ injury in models of hepatic ischemia-reperfusion and endotoxemia. Shock, 10, 20-25 (1998). 
    35. Xu, Y. G., Zhang, J. X., Hua, W. Y., and Zhu, D. Y., Synthesis and nNOS inhibitory activity of benzenealkyl isothiourea compounds. Yao Xue Xue Bao, 38, 586-591 (2003). 
    36. Zhang, H. B., Zhang, Y. A., Wu, G. Z., Zhou, J. P., Huang, W. L., and Hu, X. W., Synthesis and biological evaluation of sulfonylurea and thiourea derivatives substituted with benzenesulfonamide groups as potential hypoglycemic agents. Bioorg. Med. Chem. Lett., 19, 1740-1744 (2009). 
    37. Zhong, Z., Xing, R., Liu, S., Wang, L., Cai, S., and Li, P., Synthesis of acyl thiourea derivatives of chitosan and their antimicrobial activities in vitro. Carbohydr. Res., 343, 566-570 (2008). 
    38. Iwai, N., Ebata, T., Nagura, H., Kitazume, T., Nagai, K., and Wachi, M., Structure-activity relationship of S-benzylisothiourea derivatives to induce spherical cells in Escherichia coli. Biosci. Biotechnol. Biochem., 68, 2265-2269 (2004). 
    39. Jesko, H. A., Chalimoniuk, M., and Strosznajder, J. B., Activation of constitutive nitric oxide synthase(s) and absence of inducible isoform in aged rat brain. Neurochem. Int., 42, 315-322 (2003). 
    40. Perlovich, G. L., Proshin, A. N., Volkova, T. V., Kurkov, S. V., Grigoriev, V. V., Petrova, L. N., and Bachurin, S. O., Novel isothiourea derivatives as potent neuroprotectors and cognition enhancers: synthesis, biological and physicochemical properties. J. Med. Chem., 52, 1845-1852 (2009). 
    41. Szabo, C., Southan, G. J., and Thiemermann, C., Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase. Proc. Natl. Acad. Sci. U.S.A., 91, 12472-12476 (1994). 
  • 이 논문을 인용한 문헌 (1)

    1. Cho, Seung-Sik ; Hong, Joon-Hee ; Chae, Jung-Il ; Shim, Jung-Hyun ; Na, Chong-Sam ; Yoo, Jin-Cheol 2014. "Biological Evaluation of Nargenicin and Its Derivatives as Antimicrobial Anti-inflammatory Agents" 韓國有機農業學會誌 = Korean journal of organic agriculture, 22(3): 469~481     

 활용도 분석

  • 상세보기

    amChart 영역
  • 원문보기

    amChart 영역


  • 원문이 없습니다.

유료 다운로드의 경우 해당 사이트의 정책에 따라 신규 회원가입, 로그인, 유료 구매 등이 필요할 수 있습니다. 해당 사이트에서 발생하는 귀하의 모든 정보활동은 NDSL의 서비스 정책과 무관합니다.

원문복사신청을 하시면, 일부 해외 인쇄학술지의 경우 외국학술지지원센터(FRIC)에서
무료 원문복사 서비스를 제공합니다.

NDSL에서는 해당 원문을 복사서비스하고 있습니다. 위의 원문복사신청 또는 장바구니 담기를 통하여 원문복사서비스 이용이 가능합니다.

이 논문과 함께 출판된 논문 + 더보기